Literature DB >> 12223560

Beta-adrenoceptor agonists stimulate endothelial nitric oxide synthase in rat urinary bladder urothelial cells.

Lori A Birder1, Michele L Nealen, Susanna Kiss, William C de Groat, Michael J Caterina, Edward Wang, Gerard Apodaca, Anthony J Kanai.   

Abstract

We have investigated the intracellular signaling mechanisms underlying the release of nitric oxide (NO) evoked by beta-adrenoceptor (AR) agonists in urinary bladder strips and cultured bladder urothelial cells from adult rats. Reverse transcription-PCR revealed that inducible NO synthase and endothelial NOS but not neuronal NOS genes were expressed in urothelial cells. NO release from both urothelial cells and bladder strips was decreased (37-42%) in the absence of extracellular Ca2+ (100 microm EGTA) and was ablated after incubation with BAPTA-AM (5 microm) or caffeine (10 mm), indicating that the NO production is mediated in part by intracellular calcium stores. NO release was reduced (18-24%) by nifedipine (10 microm) and potentiated (29-32%) by incubation with the Ca2+ channel opener BAYK8644 (1-10 microm). In addition, beta-AR-evoked NO release (isoproterenol; dobutamine; terbutaline; 10(-9) to 10(-5) m) was blocked by the NOS inhibitors N(G)-nitro-L-arginine methyl ester (30 microm) or N(G)-monomethyl-L-arginine (50 microm), by beta-adrenoceptor antagonists (propranol, beta1/beta2; atenolol, beta1; ICI 118551; beta2; 100 microm), or by the calmodulin antagonist trifluoperazine (50 microm). Incubating cells with the nonhydrolyzable GTP analog GTPgammaS (1 microm) or the membrane-permeant cAMP analog dibutyryl-cAMP (10-100 microm) directly evoked NO release. Forskolin (10 microm) or the phosphodiesterase IBMX (50 microm) enhanced (39-42%) agonist-evoked NO release. These results indicate that beta-adrenoceptor stimulation activates the adenylate cyclase pathway in bladder epithelial cells and initiates an increase in intracellular Ca2+ that triggers NO production and release. These findings are considered in light of recent reports that urothelial cells may exhibit a number of "neuron-like" properties, including the expression of receptors/ion channels similar to those found in sensory neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12223560      PMCID: PMC6758083     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

Review 1.  Nitric oxide in the lower urinary tract: physiological and pathological implications.

Authors:  F H Mumtaz; M A Khan; C S Thompson; R J Morgan; D P Mikhailidis
Journal:  BJU Int       Date:  2000-03       Impact factor: 5.588

2.  Urothelium-derived inhibitory factor(s) influences on detrusor muscle contractility in vitro.

Authors:  M H Hawthorn; C R Chapple; M Cock; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

Review 3.  Primary uroepithelial cultures. A model system to analyze umbrella cell barrier function.

Authors:  S T Truschel; W G Ruiz; T Shulman; J Pilewski; T T Sun; M L Zeidel; G Apodaca
Journal:  J Biol Chem       Date:  1999-05-21       Impact factor: 5.157

4.  Neuronal and endothelial nitric oxide synthase expression in outer medulla of streptozotocin-induced diabetic rat kidney.

Authors:  S J Shin; F J Lai; J D Wen; P J Hsiao; M C Hsieh; T F Tzeng; H C Chen; J Y Guh; J H Tsai
Journal:  Diabetologia       Date:  2000-05       Impact factor: 10.122

5.  Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.

Authors:  J N Trochu; V Leblais; Y Rautureau; F Bévérelli; H Le Marec; A Berdeaux; C Gauthier
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Bladder instillation and intraperitoneal injection of Escherichia coli lipopolysaccharide up-regulate cytokines and iNOS in rat urinary bladder.

Authors:  L E Olsson; M A Wheeler; W C Sessa; R M Weiss
Journal:  J Pharmacol Exp Ther       Date:  1998-03       Impact factor: 4.030

7.  Role of the beta(3)-adrenoceptor in urine storage in the rat: comparison between the selective beta(3)-adrenoceptor agonist, CL316, 243, and various smooth muscle relaxants.

Authors:  H Takeda; Y Yamazaki; M Akahane; Y Igawa; Y Ajisawa; O Nishizawa
Journal:  J Pharmacol Exp Ther       Date:  2000-06       Impact factor: 4.030

8.  Adrenergic- and capsaicin-evoked nitric oxide release from urothelium and afferent nerves in urinary bladder.

Authors:  L A Birder; G Apodaca; W C De Groat; A J Kanai
Journal:  Am J Physiol       Date:  1998-08

9.  Shear stress induces ATP-independent transient nitric oxide release from vascular endothelial cells, measured directly with a porphyrinic microsensor.

Authors:  A J Kanai; H C Strauss; G A Truskey; A L Crews; S Grunfeld; T Malinski
Journal:  Circ Res       Date:  1995-08       Impact factor: 17.367

10.  Localization of nitric oxide synthase activity in the human lower urinary tract and its correlation with neuroeffector responses.

Authors:  I Ehrén; H Iversen; O Jansson; J Adolfsson; N P Wiklund
Journal:  Urology       Date:  1994-11       Impact factor: 2.649

View more
  64 in total

1.  Functional investigation of β-adrenoceptors in human isolated detrusor focusing on the novel selective β3-adrenoceptor agonist KUC-7322.

Authors:  Yasuhiko Igawa; Tim Schneider; Yoshinobu Yamazaki; Satoshi Tatemichi; Yukio Homma; Osamu Nishizawa; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-05-29       Impact factor: 3.000

2.  Additive effects of intravenous and intravesical application of vibegron, a β3-adrenoceptor agonist, on bladder function in rats with bladder overactivity.

Authors:  Akira Furuta; Yasuyuki Suzuki; Taro Igarashi; Yusuke Koike; Takahiro Kimura; Shin Egawa; Naoki Yoshimura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-18       Impact factor: 3.000

Review 3.  How does the urothelium affect bladder function in health and disease? ICI-RS 2011.

Authors:  L A Birder; M Ruggieri; M Takeda; G van Koeveringe; S Veltkamp; C Korstanje; B Parsons; C H Fry
Journal:  Neurourol Urodyn       Date:  2012-01-24       Impact factor: 2.696

4.  Nitric oxide regulates endocytosis by S-nitrosylation of dynamin.

Authors:  Gaofeng Wang; Nader H Moniri; Kentaro Ozawa; Jonathan S Stamler; Yehia Daaka
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 5.  Mechanisms of disease: involvement of the urothelium in bladder dysfunction.

Authors:  Lori A Birder; William C de Groat
Journal:  Nat Clin Pract Urol       Date:  2007-01

Review 6.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

7.  Expression and function of bradykinin B1 and B2 receptors in normal and inflamed rat urinary bladder urothelium.

Authors:  Bikramjit Chopra; Stacey R Barrick; Susan Meyers; Jonathan M Beckel; Mark L Zeidel; Anthony P D W Ford; William C de Groat; Lori A Birder
Journal:  J Physiol       Date:  2004-12-02       Impact factor: 5.182

8.  Differential effect of L-cysteine in isolated whole-bladder preparations from neonatal and adult rats.

Authors:  Hacer S G Büyüknacar; Cemil Göçmen; William C de Groat; Eda K Kumcu; Hsi-Yang Wu; Serpil Onder
Journal:  J Pharmacol Exp Ther       Date:  2010-01-05       Impact factor: 4.030

9.  An ex vivo bladder model with detrusor smooth muscle removed to analyse biologically active mediators released from the suburothelium.

Authors:  Leonie Durnin; Benjamin Kwok; Priya Kukadia; Roisin McAvera; Robert D Corrigan; Sean M Ward; Ying Zhang; Qi Chen; Sang Don Koh; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  J Physiol       Date:  2018-11-02       Impact factor: 5.182

10.  Effects of beta3-adrenergic receptor activation on rat urinary bladder hyperactivity induced by ovariectomy.

Authors:  F Aura Kullmann; Brian J Limberg; Debra E Artim; Mansi Shah; Thomas R Downs; Dan Contract; John Wos; Jan S Rosenbaum; William C de Groat
Journal:  J Pharmacol Exp Ther       Date:  2009-06-10       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.